Insider trading

Period: 120 months Stock: DNLI Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

226 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

226 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

226 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

226 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
226 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
226 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

226 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
15 Feb 2023
Ho Carole Chief Medical Officer · indirect
Sold, plan not stated
$43.39K 1,476 at 29.40
0.8%
13 Feb 2023
Watts Ryan J. President and CEO · indirect
Sold, plan not stated 2×
$1.02M 33,815 at 30.08
1.5%
13 Feb 2023
Schuth Alexander O. COFO and Secretary · indirect
Sold, plan not stated
$105.22K 3,497 at 30.09
0.7%
13 Feb 2023
Ho Carole Chief Medical Officer · indirect
Sold, plan not stated
$76.69K 2,548 at 30.10
1.4%
13 Feb 2023
Krognes Steve E. Director
Sold, plan not stated
$63.78K 2,119 at 30.10
1.5%
10 Feb 2023
Watts Ryan J. President and CEO · indirect
Sold, plan not stated
$727.50K 25,000 at 29.10
1.1%
10 Feb 2023
Ho Carole Chief Medical Officer · indirect
Sold, plan not stated
$24.38K 818 at 29.80
0.5%
9 Feb 2023
Watts Ryan J. President and CEO · indirect
Sold, plan not stated
$105.02K 3,433 at 30.59
0.2%
8 Feb 2023
Schuth Alexander O. COFO and Secretary · indirect
Sold, plan not stated
$46.98K 1,521 at 30.89
0.3%
8 Feb 2023
Ho Carole Chief Medical Officer · indirect
Sold, plan not stated
$46.97K 1,521 at 30.88
0.8%
8 Feb 2023
Krognes Steve E. Director
Sold, plan not stated
$42.52K 1,377 at 30.88
0.9%
17 Jan 2023
Schuth Alexander O. COFO and Secretary · indirect
Sold, plan not stated 2×
$295.34K 10,000 at 29.53
2.0%
9 Jan 2023
Ho Carole Chief Medical Officer · indirect
Sold, plan not stated
$41.55K 1,459 at 28.48
0.8%
6 Jan 2023
Ho Carole Chief Medical Officer · indirect
Sold, plan not stated
$41.60K 1,451 at 28.67
0.8%
5 Jan 2023
Watts Ryan J. President and CEO · indirect
Sold, plan not stated
$136.51K 4,800 at 28.44
0.2%
5 Jan 2023
Krognes Steve E. Director
Sold, plan not stated
$84.47K 2,970 at 28.44
2.0%
5 Jan 2023
Schuth Alexander O. COFO and Secretary · indirect
Sold, plan not stated
$74.97K 2,636 at 28.44
0.5%
5 Jan 2023
Ho Carole Chief Medical Officer · indirect
Sold, plan not stated
$74.97K 2,636 at 28.44
1.4%
4 Jan 2023
Watts Ryan J. President and CEO · indirect
Sold, plan not stated
$144.48K 5,029 at 28.73
0.2%
4 Jan 2023
Schuth Alexander O. COFO and Secretary
Sold, plan not stated
$83.57K 2,912 at 28.70
1.9%
4 Jan 2023
Ho Carole Chief Medical Officer · indirect
Sold, plan not stated
$83.57K 2,913 at 28.69
1.6%
23 Nov 2022
Sold, plan not stated
$609.60K 20,000 at 30.48
1.1%
2 Nov 2022
Sold, plan not stated
$341.27K 11,252 at 30.33
0.6%
1 Nov 2022
Sold, plan not stated
$264.19K 8,748 at 30.20
0.5%
28 Sep 2022
Sold, plan not stated 2×
$616.30K 20,000 at 30.82
1.0%
23 Aug 2022
Sold, plan not stated 2×
$632.28K 20,000 at 31.61
1.0%
23 Aug 2022
Ho Carole Chief Medical Officer · indirect
Sold, plan not stated
$77.52K 2,424 at 31.98
1.4%
19 Aug 2022
Schuth Alexander O. COFO and Secretary · indirect
Sold, plan not stated
$85.57K 2,576 at 33.22
0.5%
19 Aug 2022
Ho Carole Chief Medical Officer · indirect
Sold, plan not stated
$85.57K 2,576 at 33.22
1.5%
19 Aug 2022
Watts Ryan J. President and CEO · indirect
Sold, plan not stated
$79.86K 2,404 at 33.22
0.1%
19 Aug 2022
Krognes Steve E. Director
Sold, plan not stated
$74.84K 2,253 at 33.22
1.5%
25 Jul 2022
Sold, plan not stated 2×
$712.11K 20,000 at 35.61
1.0%
23 Mar 2022
Sold, plan not stated 2×
$676.58K 20,000 at 33.83
1.0%
11 Feb 2022
Watts Ryan J. President and CEO · indirect
Sold, plan not stated
$329.53K 9,491 at 34.72
0.4%
11 Feb 2022
Ho Carole Chief Medical Officer · indirect
Sold, plan not stated
$101.28K 2,918 at 34.71
1.7%
11 Feb 2022
Schuth Alexander O. COO and Secretary · indirect
Sold, plan not stated
$97.21K 2,803 at 34.68
0.6%
11 Feb 2022
Krognes Steve E. CFO and Treasurer
Sold, plan not stated
$88.81K 2,560 at 34.69
2.1%
9 Feb 2022
Watts Ryan J. President and CEO · indirect
Sold, plan not stated
$102.10K 2,719 at 37.55
0.1%
9 Feb 2022
Schuth Alexander O. COO and Secretary · indirect
Sold, plan not stated
$52.80K 1,423 at 37.10
0.3%
9 Feb 2022
Ho Carole Chief Medical Officer · indirect
Sold, plan not stated
$52.79K 1,423 at 37.10
0.8%
9 Feb 2022
Krognes Steve E. CFO and Treasurer
Sold, plan not stated
$48.07K 1,296 at 37.09
1.0%
5 Jan 2022
Watts Ryan J. President and CEO · indirect
Sold, plan not stated
$224.21K 5,007 at 44.78
0.2%
5 Jan 2022
Schuth Alexander O. COO and Secretary · indirect
Sold, plan not stated
$127.42K 2,846 at 44.77
0.6%
5 Jan 2022
Ho Carole Chief Medical Officer · indirect
Sold, plan not stated
$127.40K 2,845 at 44.78
1.7%
5 Jan 2022
Krognes Steve E. CFO and Treasurer
Sold, plan not stated
$99.57K 2,225 at 44.75
1.8%
30 Dec 2021
Tessier-Lavigne Marc Director · indirect
Sold, plan not stated 6×
$909.36K 20,047 at 45.36
20.3%
29 Dec 2021
Tessier-Lavigne Marc Director · indirect
Sold, plan not stated 3×
$1.41M 32,104 at 43.88
27.3%
28 Dec 2021
Tessier-Lavigne Marc Director · indirect
Sold, plan not stated 3×
$487.22K 10,980 at 44.37
10.2%
6 Dec 2021
Schuth Alexander O. COO and Secretary · indirect
Sold, plan not stated 2×
$422.74K 10,000 at 42.27
2.2%
6 Dec 2021
Ho Carole Chief Medical Officer
Sold, plan not stated
$62.76K 1,476 at 42.52
1.9%
Showing 1–50 of 226. Page 1 of 5 Older →